Rankings
▼
Calendar
NAGE Q3 2016 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$392M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$2M
47.3% margin
Operating Income
-$924,162
-23.5% margin
Net Income
-$954,390
-24.2% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
-55.4%
Cash Flow
Operating Cash Flow
-$140,395
Free Cash Flow
-$860,172
Stock-Based Comp.
$272,389
Balance Sheet
Total Assets
$19M
Total Liabilities
$7M
Stockholders' Equity
$12M
Cash & Equivalents
$2M
← FY 2016
All Quarters
Q4 2016 →